Navigation Links
Baron and Budd Supports the Newest Drug Being Tested for Mesothelioma Treatment
Date:8/5/2013

LOS ANGELES (PRWEB) August 05, 2013

Baron and Budd is proud to announce the Food and Drug Administration’s approval of a new drug to be used for the treatment of the rare cancer, mesothelioma, that occurs because of exposure to asbestos. This new drug is called VS-6036, or defactinib, and is a cancer-stem-cell inhibitor that is manufactured by Verastem Inc. (VSTM). (http://online.wsj.com/article/BT-CO-20130724-707069.html?mod=googlenews_wsj)

VS-6036 is being developed thanks to the Food and Drug Administration’s orphan drug designation that assists the development of drugs treating rare conditions affecting 200,000 patients or less within the U.S. With this designation, VS-6036 has been given assistance from the Food and Drug Administration in clinical trial development, pardon from the standard Food and Drug Administration user fees and a seven-year market exclusivity period after approval. (http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/HowtoapplyforOrphanProductDesignation/default.htm)

Up to 400 patients are planned to enroll in clinical trial sites in 11 countries for the VS-6036 clinical study for patients suffering from pleural mesothelioma.

“We are encouraged by the work of the FDA and Verastem Inc. to better the lives of those suffering from mesothelioma," said Russell Budd of Baron and Budd. “While the FDA and Verastem Inc. prepare the VS-6036 clinical trial, we will continue to work to make sure that one day the need for mesothelioma treatment is irrelevant. We believe that a global ban on asbestos is imperative."

To find out more about asbestos exposure, mesothelioma and the road toward banning asbestos use within the United States, visit http://baronandbudd.com/areas-of-practice/mesothelioma-attorney/

Baron and Budd is an active participant in asbestos advocacy and mesothelioma education on a national scale. The law firm supports the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the countries’ top cancer treatment centers. With financial support from Baron and Budd, the NCCN has been able to produce and distribute a treatment resource detailing the Clinical Guidelines for Mesothelioma, titled the Patient Guidelines for Mesothelioma. Baron and Budd is also a repeat platinum sponsor of an international non-profit organization committed to banning asbestos and assisting patients suffering from mesothelioma, the Asbestos Disease Awareness Organization (ADAO). Baron and Budd was also an inaugural donor to the International Mesothelioma Program (IMP) at Brigham and Women’s Hospital in Boston.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10993175.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
2. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
3. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
4. Study supports urate protection against Parkinsons disease, hints at novel mechanism
5. Dietary fiber alters gut bacteria, supports gastrointestinal health
6. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
7. NIDA supports development of combined anti-heroin and HIV vaccine
8. Little evidence supports autism treatment options in adolescents
9. $1.8 million grant supports investigation of psoriasis link to cardiovascular disease
10. John Templeton Foundation grant supports Princeton neuroscientists to study cognitive control
11. Human umbilical cord blood cell co-culture supports embryonic stem cell expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Phycologia ... A (UV-A) for photosynthesis, researchers Juntian Xu and Kunshan Gao tested the magnitude ... pair observed that when photosynthetically active radiation (i.e. the white light in our ...
(Date:5/5/2016)... ... 05, 2016 , ... Derrin Doty Group has unveiled the latest charity campaign ... communities west of Seattle. The insurance provider’s caring team has been so moved by ... due to complications from the flu, that they have decided to extend their original ...
(Date:5/5/2016)... ... May 05, 2016 , ... The University of ... to host the 2016 National SACA Leadership Conference on the Portland campus September ... chapter officers to come together and develop skills to be future leaders in ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Vitenas Cosmetic Surgery ... Design Awards, presented by the American Institute of Architects and the Academy of Architecture ... the renowned Perkins+Will and Harrell Architects, opened to patients in October of 2014. ...
(Date:5/5/2016)... ... , ... Dr. Benjamin Stong of Kalos Facial Plastic Surgery, LLC in Atlanta, ... double board certified and the only facial plastic surgeon in Atlanta to offer ... such as stem cells can be used to provide stabilization to hair transplant results ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... According to market research "Global ... and Demand Forecast to 2022 - Industry Insights by ... Very High Field, Low to Mid Field, and Ultra ... Musculoskeletal, Vascular, Breast, Pelvic and Abdomen, Cardiac, and Other)" ... market was valued at $5,351.7 million in 2015, and ...
(Date:5/3/2016)... , May 3, 2016 Intec ... a clinical-stage biopharmaceutical company, today announced the appointment of ... Regulatory Affairs. "Ms. Strauss-Levy has 15 years ... has established an outstanding track record, having supported the ... regulatory approval processes in the United States ...
(Date:5/3/2016)... Global and Chinese Surgical ... overview of the industry that covers definition, applications ... report explores into the international and Chinese players ... Surgical Mesh market spread across 150 pages providing ... is available at http://www.reportsnreports.com/reports/470569-global-and-chinese-surgical-mesh-industry-2016-market-research-report.html . ...
Breaking Medicine Technology: